Levonorgestrel Ethinylestradiol Eugia

Ethinylestradiol / Levonorgestrel, the active ingredients in Levonorgestrel Ethinylestradiol Eugia, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age.

GNH USA supplies Levonorgestrel Ethinylestradiol Eugia as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel Ethinylestradiol Eugia is a combined oral contraceptive used to prevent pregnancy.

- Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed. - Hormonal contraception: offers reversible control of fertility for women of child‑bearing potential. - Cycle regulation: helps achieve more predictable menstrual bleeding patterns when used consistently.

Levonorgestrel Ethinylestradiol Eugia may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting: irregular bleeding between periods. - Mood changes: irritability or mild depressive symptoms. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung arteries. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: heart attack risk, especially in high‑risk groups. - Severe allergic reaction: anaphylaxis with rash, swelling, or breathing difficulty. - Liver tumor: rare hepatic adenoma development.

Before prescribing Levonorgestrel Ethinylestradiol Eugia, clinicians should consider several safety factors.

- Contraindications: Do not use in women with a history of thromboembolic disorders, estrogen‑dependent tumors, or uncontrolled hypertension. - Smoking: Avoid in patients over 35 who smoke, due to increased cardiovascular risk. - Medication review: Assess concomitant drugs that may reduce contraceptive efficacy. - Pregnancy testing: Confirm patient is not pregnant before initiating therapy. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Levonorgestrel Ethinylestradiol Eugia can interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may lower hormone levels and increase pregnancy risk. - Rifampin and rifabutin: reduce contraceptive efficacy by enhancing hepatic metabolism. - Griseofulvin: decreases plasma concentrations of both hormones. - St. John’s wort: may diminish contraceptive protection.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): can raise hormone levels, heightening side‑effect potential. - Protease inhibitor antiretrovirals (e.g., ritonavir): may alter hormone metabolism. - Selective serotonin reuptake inhibitors (SSRIs): may increase incidence of nausea and headache.